This article provides a comprehensive overview of Comparative Effectiveness Research (CER) in the pharmaceutical sector, tailored for researchers, scientists, and drug development professionals.
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on the critical practices of assessing model robustness using Y-randomization and Applicability Domain (AD) analysis.
This comprehensive review examines current methodologies and challenges in validating computational models for predicting human cytochrome P450 inhibition, a critical factor in drug safety assessment.
This article provides a comprehensive framework for evaluating machine learning models that predict Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) properties.
This article provides a comprehensive analysis for researchers and drug development professionals on the predictive accuracy of computational models for natural versus synthetic compounds.
Accurate prediction of Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) properties is crucial for reducing late-stage failures in drug discovery.
This article provides a comprehensive framework for researchers and drug development professionals to effectively validate in silico ADMET predictions with robust in vitro data.
This article provides a comprehensive, evidence-based benchmark of open-access and commercial ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) prediction tools for researchers and drug development professionals.
This article provides a comprehensive guide for researchers and drug development professionals on validating machine learning (ML) models for industrial ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) prediction.
The integration of artificial intelligence, particularly deep learning (DL), is revolutionizing Quantitative Structure-Activity Relationship (QSAR) modeling in drug discovery.